Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Syprine
2. Trien
3. Trientine
4. Trientine Dihydrochloride
5. Triethylenetetramine
1. Triethylenetetramine Dihydrochloride
2. 38260-01-4
3. Syprine
4. Trientine Dihydrochloride
5. Trientine Hcl
6. Mk-0681
7. 1,2-ethanediamine, N,n'-bis(2-aminoethyl)-, Dihydrochloride
8. Triethylene Tetramine Dihydrochloride
9. Teta
10. N,n'-bis(2-aminoethyl)-1,2-ethanediamine Dihydrochloride
11. Hc3nx54582
12. Nsc-759164
13. N1,n1'-(ethane-1,2-diyl)bis(ethane-1,2-diamine) Dihydrochloride
14. Trien Dihydrochloride
15. Cuprid
16. 1,2-ethanediamine,n1,n2-bis(2-aminoethyl)-, Hydrochloride (1:2)
17. Trientine Hydrochloride [usan]
18. Einecs 253-854-3
19. Mk 0681
20. N,n'-bis(2-aminoethyl)ethylenediamine Dihydrochloride
21. Laszarin
22. Metalite
23. Unii-hc3nx54582
24. Trientine-2hcl
25. 2,2'-ethylenediiminobis(ethylamine) Dihydrochloride
26. Syprine (tn)
27. Trientine Hydrochloride [usan:usp]
28. Trientinedihydrochloride
29. Triethyl Enetetramine 2hcl
30. Schembl506189
31. Chebi:9706
32. Chembl3989777
33. Dtxsid2057863
34. Amy3335
35. Tja-250
36. Mk-681
37. N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;dihydrochloride
38. S6585
39. Trientine Hydrochloride (jp17/usp)
40. Trientine Hydrochloride [jan]
41. Trientine Dihydrochloride [mi]
42. Akos028109579
43. Ccg-213505
44. Nsc 759164
45. Trientine Hydrochloride [vandf]
46. Trientine Hydrochloride [usp-rs]
47. Trientine Dihydrochloride [mart.]
48. Bs-49370
49. Trientine Dihydrochloride [who-dd]
50. Db-049259
51. Ft-0639448
52. Trientine Hydrochloride [orange Book]
53. D00736
54. E78246
55. Trientine Hydrochloride [usp Monograph]
56. 260t014
57. Q27279855
58. N1,n1'-(ethane-1,2-diyl)diethane-1,2-diamine Dihydrochloride
59. N\'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine,dihydrochloride
60. Trientine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
61. Triethylenetetramine Dihydrochloride, Puriss., 2xcryst., >=99.0% (at)
62. Trientine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Molecular Weight | 219.15 g/mol |
---|---|
Molecular Formula | C6H20Cl2N4 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 218.1065020 g/mol |
Monoisotopic Mass | 218.1065020 g/mol |
Topological Polar Surface Area | 76.1 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 49.7 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Syprine |
PubMed Health | Trientine (By mouth) |
Drug Classes | Heavy Metal Chelator |
Drug Label | Trientine hydrochloride is N,N'-bis (2-aminoethyl)-1,2-ethanediamine dihydrochloride. It is a white to pale yellow crystalline hygroscopic powder. It is freely soluble in water, soluble in methanol, slightly soluble in ethanol, and insoluble in chlor |
Active Ingredient | Trientine hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 250mg |
Market Status | Prescription |
Company | Aton |
2 of 2 | |
---|---|
Drug Name | Syprine |
PubMed Health | Trientine (By mouth) |
Drug Classes | Heavy Metal Chelator |
Drug Label | Trientine hydrochloride is N,N'-bis (2-aminoethyl)-1,2-ethanediamine dihydrochloride. It is a white to pale yellow crystalline hygroscopic powder. It is freely soluble in water, soluble in methanol, slightly soluble in ethanol, and insoluble in chlor |
Active Ingredient | Trientine hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 250mg |
Market Status | Prescription |
Company | Aton |
Cufence is indicated for the treatment of Wilsons disease in patients intolerant to D-Penicillamine therapy, in adults and children aged 5 years or older.
Chelating Agents
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)
A16A
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-12-23
Pay. Date : 2016-09-13
DMF Number : 30878
Submission : 2016-11-08
Status : Active
Type : II
Date of Issue : 2024-02-20
Valid Till : 2026-12-06
Written Confirmation Number : WC-0416
Address of the Firm :
NDC Package Code : 58159-031
Start Marketing Date : 2019-10-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-12-15
Pay. Date : 2015-09-21
DMF Number : 29019
Submission : 2015-09-25
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-03-01
Pay. Date : 2015-09-15
DMF Number : 29527
Submission : 2015-09-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37777
Submission : 2022-12-16
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-04-17
Pay. Date : 2017-02-22
DMF Number : 31395
Submission : 2017-02-23
Status : Active
Type : II
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0226
Address of the Firm :
NDC Package Code : 14593-914
Start Marketing Date : 2023-09-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (15kg/15kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-03-17
Pay. Date : 2016-09-14
DMF Number : 30905
Submission : 2016-09-15
Status : Active
Type : II
Date of Issue : 2022-09-30
Valid Till : 2025-09-08
Written Confirmation Number : WC-0369n
Address of the Firm :
NDC Package Code : 76339-133
Start Marketing Date : 2019-09-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (9.999kg/9.999kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-09-14
Pay. Date : 2017-08-17
DMF Number : 31085
Submission : 2016-12-02
Status : Active
Type : II
Date of Issue : 2020-04-15
Valid Till : 2023-05-19
Written Confirmation Number : WC-0281new2
Address of the Firm :
NDC Package Code : 50379-0017
Start Marketing Date : 2015-10-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-09-03
Pay. Date : 2018-07-17
DMF Number : 32956
Submission : 2018-07-19
Status : Active
Type : II
Date of Issue : 2019-07-15
Valid Till : 2022-07-14
Written Confirmation Number : WC-0042
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5351
Submission : 1984-05-17
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-07-03
Application Number : 211076
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-09-16
Application Number : 209415
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Australia
Brand Name : Trientine Waymade
Dosage Form :
Dosage Strength :
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-05-22
Application Number : 211134
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2023-09-22
Application Number : 212238
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablets
Dosage Strength : 250mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Italy
Brand Name : TRIENTINA WAYMADE
Dosage Form : Hard Capsules
Dosage Strength : 200 mg
Packaging : 100 UNITS 200 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-04-26
Application Number : 211554
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2019-07-03
Application Number : 211076
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2018-02-07
Application Number : 207567
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2019-02-08
Application Number : 210619
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code : AB
Brand Name : SYPRINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 1985-11-08
Application Number : 19194
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : No
TE Code :
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2020-05-21
Application Number : 211637
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2019-05-22
Application Number : 211134
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2019-01-16
Application Number : 211251
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2020-02-20
Application Number : 212238
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 500MG
Approval Date : 2023-09-22
Application Number : 212238
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code : AB
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2019-04-26
Application Number : 211554
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Related Excipient Companies
Excipients by Applications
Global Sales Information
Company :
Trientine HCl
Drug Cost (USD) : 617,408
Year : 2022
Prescribers :
Prescriptions : 36
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Trientine HCl
Drug Cost (USD) : 5,587,864
Year : 2022
Prescribers : 109
Prescriptions : 877
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Trientine HCl
Drug Cost (USD) : 766,879
Year : 2021
Prescribers :
Prescriptions : 47
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Trientine HCl
Drug Cost (USD) : 5,059,788
Year : 2021
Prescribers : 98
Prescriptions : 805
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Trientine HCl
Drug Cost (USD) : 2,666,049
Year : 2020
Prescribers : 12
Prescriptions : 90
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Trientine HCl
Drug Cost (USD) : 2,956,834
Year : 2019
Prescribers : 26
Prescriptions : 113
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Trientine HCl
Drug Cost (USD) : 9,841,906
Year : 2019
Prescribers : 80
Prescriptions : 639
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Trientine HCl
Drug Cost (USD) : 7,959,440
Year : 2018
Prescribers : 74
Prescriptions : 353
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Trientine HCl
Drug Cost (USD) : 6,198,477
Year : 2018
Prescribers : 66
Prescriptions : 390
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Trientine HCl
Drug Cost (USD) : 13,236,187
Year : 2017
Prescribers : 88
Prescriptions : 658
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Dosage Form : Hard Capsule Oral Use Bottle
Dosage Strength : 200 mg
Price Per Pack (Euro) : 3,782.79
Published in :
Country : Italy
RX/OTC/DISCN :
Dosage Form : Hard Capsules
Dosage Strength : 200 mg
Price Per Pack (Euro) : 2,647.95
Published in :
Country : Italy
RX/OTC/DISCN :
Future Health Pharma GmbH
Dosage Form : Caps
Dosage Strength : 250mg
Price Per Pack (Euro) : 2314.55
Published in :
Country : Switzerland
RX/OTC/DISCN : Class B
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Ideogen AG
Dosage Form : Caps
Dosage Strength : 250mg
Price Per Pack (Euro) : 4117.12
Published in :
Country : Switzerland
RX/OTC/DISCN : Class B
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2016 Revenue in Millions : 88
2015 Revenue in Millions : 89
Growth (%) : -1
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2017 Revenue in Millions : 91
2016 Revenue in Millions : 88
Growth (%) : 3
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2018 Revenue in Millions : 47
2017 Revenue in Millions : 91
Growth (%) : -48%
Market Place
Reply
19 Jan 2022
Reply
17 Mar 2021
Reply
03 Apr 2019
Reply
08 Apr 2016
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?